Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects

NCT02256826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BILR 355 BS
DRUG: Ritonavir (RTV)
DRUG: Kaletra®

Sponsor

Boehringer Ingelheim